WordNet

the approximate amount of something (usually used prepositionally as in `in the region of' (同)neighborhood
the extended spatial location of something; "the farming regions of France"; "religions in all parts of the world"; "regions of outer space" (同)part
a knowledge domain that you are interested in or are communicating about; "it was a limited realm of discourse"; "here we enter the region of opinion"; "the realm of the occult" (同)realm
a large indefinite location on the surface of the Earth; "penguins inhabit the polar regions"
a relation between two opposite states or principles that together exhaust the possibilities
the interrelation of reciprocity whereby one thing supplements or depends on the other; "the complementarity of the sexes"

PrepTutorEJDIC

(地理的な)『地域』,『地帯』;(特に広大な)地方 / 《複数形で》(宇宙などの)区分,界,属 / (身体の)部分 / (学問などの)分野,領域 / 《複数形で》(都会から離れた)地方

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/02/26 07:23:42」(JST)

wiki en

The "upper" part (Fab region) of an antibody. The complementarity determining regions of the heavy chain are shown in red (PDB 1IGT).

Complementarity determining regions (CDRs) are part of the variable chains in immunoglobulins (antibodies) and T cell receptors, generated by B-cells and T-cells respectively, where these molecules bind to their specific antigen. As the most variable parts of the molecules, CDRs are crucial to the diversity of antigen specificities generated by lymphocytes.

Location and structure

Sketch of an antibody with the variable domains shown in blue, and the CDRs (which are part of the variable domains) in light blue.

In the amino acid sequence of a variable domain of an antigen receptor there are three CDRs (CDR1, CDR2 and CDR3), arranged non-consecutively. Since the antigen receptors are typically composed of two variable domains (on two different polypeptide chains, heavy and light chain), there are six CDRs for each antigen receptor that can collectively come into contact with the antigen. A single antibody molecule has two antigen receptors and therefore contains twelve CDRs. Sixty CDRs can be found on a pentameric IgM molecule.

Within the variable domain, CDR1 and CDR2 are found in the variable (V) region of a polypeptide chain, and CDR3 includes some of V, all of diversity (D, heavy chains only) and joining (J) regions.^[1] CDR3 is the most variable.

Since most sequence variation associated with immunoglobulins and T cell receptors are found in the CDRs, these regions are sometimes referred to as hypervariable regions.^[2] Among these, CDR3 shows the greatest variability as it is encoded by a recombination of the VJ in the case of a light chain region and VDJ in the case of heavy chain regions.

The tertiary structure of an antibody is important to analyze and design new antibodies. The three-dimensional structures of the non-H3 CDRs of antibodies have been clustered and classified by Chothia et al.^[3] and more recently by North et al.^[4] Homology modeling is a computational method to build tertiary structures from amino-acid sequences. The so-called H3-rules are empirical rules to build models of CDR3.^[5]

References

^ William E. Paul (2008). Fundamental Immunology (6th ed.). Lippincott Williams & Wilkins. ISBN 0-7817-6519-6.
^ Abbas AK and Lichtman AH (2003). Cellular and Molecular Immunology (5th ed.). Saunders, Philadelphia. ISBN 0-7216-0008-5.
^ Al-Lazikani, B.; Lesk, A. M.; Chothia, C. (1997). "Standard conformations for the canonical structures of immunoglobulins". Journal of Molecular Biology 273 (4): 927–948. doi:10.1006/jmbi.1997.1354. PMID 9367782. edit
^ North, B.; Lehmann, A.; Dunbrack Jr, R. L. (2011). "A New Clustering of Antibody CDR Loop Conformations". Journal of Molecular Biology 406 (2): 228–256. doi:10.1016/j.jmb.2010.10.030. PMC 3065967. PMID 21035459. edit
^ Shirai, H; Kidera, A; Nakamura, H (1999). "H3-rules: identification of CDR-H3 structures in antibodies". FEBS Letters 455 (1-2): 188–97. doi:10.1016/S0014-5793(99)00821-2. PMID 10428499. edit

External links

Complementarity determining regions at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 免疫グロブリンの構造 structure of immunoglobulins
2. 免疫遺伝学 immunoglobulin genetics
3. 腫瘍壊死因子α（TNF-α）阻害剤：抗体、自己抗体、および自己免疫疾患の誘導 tumor necrosis factor alpha inhibitors induction of antibodies autoantibodies and autoimmune diseases
4. 橋本病（慢性自己免疫性甲状腺炎）の病因 pathogenesis of hashimotos thyroiditis chronic autoimmune thyroiditis
5. 慢性リンパ性白血病の病態生理および遺伝学的特徴 pathophysiology and genetic features of chronic lymphocytic leukemia

English Journal

A Novel Interaction Mode between Acrylamide and its Specific Antibody.

Zhou S1, Wang D, Zhang C, Zhao Y, Zhao M, Wu Y.
Journal of immunoassay & immunochemistry.J Immunoassay Immunochem.2015;36(3):295-311. doi: 10.1080/15321819.2014.947432.
Since the discovery of high-level acrylamide (Acr) contamination in food, extensive international studies have focused on its toxicity and detection. By using a novel antigen synthetic strategy, we have successfully obtained a specific antibody towards acrylamide (Acr-Ab). Herein, the Acr-Ab and its
PMID 25215894

Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.

Beltrán E1, Obermeier B2, Moser M3, Coret F4, Simó-Castelló M5, Boscá I5, Pérez-Miralles F5, Villar LM6, Senel M7, Tumani H7, Hohlfeld R8, Casanova B5, Dornmair K9.
Brain : a journal of neurology.Brain.2014 Oct;137(Pt 10):2703-14. doi: 10.1093/brain/awu205. Epub 2014 Jul 23.
Intrathecal oligoclonal bands of the cerebrospinal fluid are considered the most important immunological biomarkers of multiple sclerosis. They typically consist of clonally expanded IgG antibodies that underwent affinity maturation during sustained stimulation by largely unknown antigens. In additi
PMID 25060097

Antibody mimetics: promising complementary agents to animal-sourced antibodies.

Baloch AR1, Baloch AW, Sutton BJ, Zhang X.
Critical reviews in biotechnology.Crit Rev Biotechnol.2014 Sep 29:1-8. [Epub ahead of print]
Abstract Despite their wide use as therapeutic, diagnostic and detection agents, the limitations of polyclonal and monoclonal antibodies have inspired scientists to design the next generation biomedical agents, so-called antibody mimetics that offer many advantages over conventional antibodies. Anti
PMID 25264572

Japanese Journal

抗体開発のための抗原抗体相互作用解析 (特集抗体デリバリー : 基礎から臨床まで)

津本浩平
Drug delivery system : DDS : official journal of the Japan Society of Drug Delivery System 28(5), 412-423, 2013-11
NAID 40019893929

Evaluation of the Aggregation States of Monoclonal Antibodies by Diverse and Complementary Methods

Yoshino Tetsuya,Ishikawa Tomoyoshi,Ishihara Takashi [他],Takeuchi Yoshimi,Yoshikawa Hitomi,Yoshida Hideaki,Yoshida Hitoshi,Wakamatsu Kaori
Biological and Pharmaceutical Bulletin 34(8), 1273-1278, 2011
… As anti-DNP1 had a longer complementarity-determining region 3 (CDR3) light chain than anti-DNP2 by 2 amino acid residues, we hypothesized that the increased aggregation of DNP1 was due to these extra residues; … The fragment antigen-binding region of this mutant was found to have lower thermal stability than the others by differential scanning calorimetry. …
NAID 130000936598

Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis

YANG Jie-Zuan,LI Ming-Wei,WANG Jian-Guo,LU Hai-Feng,YAO Xin-Sheng,HE Jian-Qin,LI Lan-Juan
Hepatology research : the official journal of the Japan Society of Hepatology 40(4), 407-414, 2010-04-01
NAID 10027291680